Your fact-checks will appear here
The use of ivermectin as a potential treatment for COVID-19, despite the FDA's warnings against it.
dosing for humans is weight‑based and used for specific ; the standard therapeutic range cited by major medical sources is about 150–200 micrograms per kilogram (0.15–0.20 mg/kg) as a single oral dose...
Several U.S. states have moved to expand access to by authorizing over‑the‑counter (OTC) sales or allowing pharmacists to dispense it without a prescription, creating a patchwork of state-level rules ...
Ivermectin dosing in humans is disease-specific and weight‑based: standard microgram-per-kilogram regimens range from about 150–200 µg/kg for onchocerciasis, strongyloidiasis and enterobiasis, to 400 ...
Ivermectin dosing is weight‑based, typically calculated in micrograms per kilogram and most often given as a single oral dose; common regimens for human parasitic infections fall between about 150 and...
Health agencies recommend vaccination, nonpharmaceutical measures (masking, ventilation, testing and isolation), and timely use of authorized or guideline-recommended medical therapies—antivirals, sel...
for humans is explicitly weight‑based: recommended therapeutic regimens are expressed in micrograms or milligrams per kilogram of body weight rather than by a fixed tablet count . A single 12 mg dose ...
Veterinary ivermectin products commonly come at far higher concentrations and in different delivery forms than human tablets, which raises real risks of overdose, neurotoxicity and other severe advers...
Two oral human ivermectin tablet products carry FDA-approved parasitic indications with weight‑based single‑dose regimens: marketed Stromectol/ivermectin tablets (designed to provide ~200 mcg/kg for s...
Clinical trials of ivermectin for COVID‑19 range from small, early randomized studies to large community and hospital trials and multiple systematic reviews; results are mixed, with some meta-analyses...
Human prescription ivermectin is supplied as regulated, weight‑based oral tablets or topical formulations at low, controlled strengths for single‑dose or short‑course use (typically ~0.15–0.20 mg/kg f...
Preclinical literature shows repeated, drug‑level interactions between ivermectin and multiple chemotherapy or targeted agents—mostly beneficial pharmacodynamic synergies (enhanced tumor cell kill, re...
Use of veterinary ivermectin formulations in humans has been repeatedly linked to overdoses and a spectrum of adverse events—most commonly gastrointestinal symptoms and neurologic problems—and has pro...
Regulatory labeling and major clinical guidance for oral generally prescribe weight‑based single doses in the 150–200 micrograms per kilogram (mcg/kg) range for approved parasitic indications, with re...
carries a defined set of clinically important that raise the risk of bleeding, neurotoxicity, and increased systemic exposure—most notably drugs that inhibit CYP3A4 or P‑glycoprotein and anticoagulant...
Human safety data for subcutaneous (SC) or intramuscular (IM) ivermectin intended for injection are extremely limited: a handful of case reports and small pharmacokinetic observations describe compass...
Randomized and observational studies have tested five‑day ivermectin regimens almost exclusively in the context of COVID‑19, producing a patchwork of contradictory results: small trials from Banglades...
Over-the-counter () ivermectin laws enacted in several U.S. states permit purchase without a prescription and, in some versions, without pharmacist consultation, while “behind‑the‑counter” models requ...
Mainstream medical agencies rejected primarily after a cascade of large, well-conducted (RCTs) failed to show clinical benefit, systematic reviews and Cochrane-level meta-analyses concluded no effect,...
commonly causes mild, transient symptoms such as itching, headache, dizziness, nausea, diarrhea and fatigue, while more serious reactions—especially neurologic events and severe allergic responses—hav...
is an antiparasitic medicine for several human parasitic infections—primarily , intestinal strongyloidiasis and other helminthiases, and in some regimens for and lice—and is available in oral and topi...